{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:49:41Z","timestamp":1789462181214,"version":"build-2803163510"},"reference-count":168,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Angiol"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fifty percent of all death from cardiovascular diseases is due to coronary artery disease (CAD). This is avoidable if early identification is made. Preventive health care has a major role in the fight against CAD. Atherosclerosis and atherosclerotic plaque rupture are involved in the development of CAD. Modifiable risk factors for CAD are dyslipidemia, diabetes, hypertension, cigarette smoking, obesity, chronic renal disease, chronic infection, high C-reactive protein, and hyperhomocysteinemia. CAD can be prevented by modification of risk factors. This paper defines the primary, secondary, and tertiary prevention of CAD. It discusses the mechanism of risk factor\u2013induced atherosclerosis. This paper describes the CAD risk score and its use in the selection of individuals for primary prevention of CAD. Guidelines for primary, secondary, and tertiary prevention of CAD have been described. Modification of risk factors and use of guidelines for prevention of CAD would prevent, regress, and slow down the progression of CAD, improve the quality of life of patient, and reduce the health care cost.<\/jats:p>","DOI":"10.1055\/s-0041-1731273","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T18:49:55Z","timestamp":1629917395000},"page":"177-186","source":"Crossref","is-referenced-by-count":26,"title":["Current Status of Primary, Secondary, and Tertiary Prevention of Coronary Artery Disease"],"prefix":"10.1055","volume":"30","author":[{"given":"Kailash","family":"Prasad","sequence":"additional","affiliation":[{"name":"Department of Physiology (APP), College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,8,25]]},"reference":[{"issue":"05","key":"ref1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrcardio.2014.26","article-title":"Epidemiological studies of CHD and the evolution of preventive cardiology","volume":"11","author":"N D Wong","year":"2014","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.CIR.99.10.1355","article-title":"Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed","volume":"99","author":"K Prasad","year":"1999","journal-title":"Circulation"},{"issue":"19","key":"ref5","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease. The Framingham study","volume":"241","author":"W B Kannel","year":"1979","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1194\/jlr.R800059-JLR200","article-title":"Diabetes and atherosclerosis: is there a role for hyperglycemia?","volume":"50","author":"A Chait","year":"2009","journal-title":"J Lipid Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/000331977502600101","article-title":"Role of blood pressure in cardiovascular disease: the Framingham Study","volume":"26","author":"W B Kannel","year":"1975","journal-title":"Angiology"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/HYPERTENSIONAHA.117.09402","article-title":"Relationship of hypertension to coronary atherosclerosis and cardiac events in patients with coronary computed tomographic angiography","volume":"70","author":"R Nakanishi","year":"2017","journal-title":"Hypertension"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/jama.279.2.119","article-title":"Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study","volume":"279","author":"G Howard","year":"1998","journal-title":"JAMA"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jacc.2003.12.047","article-title":"The pathophysiology of cigarette smoking and cardiovascular disease: an update","volume":"43","author":"J A Ambrose","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"06","key":"ref11","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/CIRCULATIONAHA.106.171016","article-title":"Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism","volume":"113","author":"P Poirier","year":"2006","journal-title":"Circulation"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrneph.2010.157","article-title":"Atherosclerosis in chronic kidney disease: the role of macrophages","volume":"7","author":"V Kon","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"05","key":"ref13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.arcmed.2015.05.006","article-title":"Infection and atherosclerosis development","volume":"46","author":"L A Campbell","year":"2015","journal-title":"Arch Med Res"},{"issue":"03","key":"ref14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/107424840400900308","article-title":"C-reactive protein increases oxygen radical generation by neutrophils","volume":"9","author":"K Prasad","year":"2004","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"02","key":"ref15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0002-9149(00)80061-2","article-title":"Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients","volume":"75","author":"C J Glueck","year":"1995","journal-title":"Am J Cardiol"},{"issue":"02","key":"ref16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-0035-1570754","article-title":"Atherosclerosis and the Hypercholesterolemic AGE-RAGE Axis","volume":"25","author":"E McNair","year":"2016","journal-title":"Int J Angiol"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0037-1613678","article-title":"AGE-RAGE stress, stressors, and antistressors in health and disease","volume":"27","author":"K Prasad","year":"2018","journal-title":"Int J Angiol"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/clc.20815","article-title":"Soluble receptors for advanced glycation end products (sRAGE) as a predictor of restenosis following percutaneous coronary intervention","volume":"33","author":"E D McNair","year":"2010","journal-title":"Clin Cardiol"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/0002-8703(93)90102-F","article-title":"Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E","volume":"125","author":"K Prasad","year":"1993","journal-title":"Am Heart J"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF02014924","article-title":"Oxygen free radicals as a mechanism of hypercholesterolemic atherosclerosis: effects of probucol","volume":"3","author":"K Prasad","year":"1994","journal-title":"Int J Angiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3389\/fphys.2017.00600","article-title":"Oxidative stress-mediated atherosclerosis: mechanisms and therapies","volume":"8","author":"X Yang","year":"2017","journal-title":"Front Physiol"},{"key":"ref22","first-page":"85","volume-title":"Pathophysiology of atherosclerosis","author":"K Prasad","year":"2000"},{"issue":"04","key":"ref23","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/1074248407307853","article-title":"A study on regression of hypercholesterolemic atherosclerosis in rabbits by flax lignan complex","volume":"12","author":"K Prasad","year":"2007","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1074248408330541","article-title":"Flax lignan complex slows down the progression of atherosclerosis in hyperlipidemic rabbits","volume":"14","author":"K Prasad","year":"2009","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1016\/S0021-9258(18)83351-8","article-title":"The regulation of platelet-activating factor production in endothelial cells. The role of calcium and protein kinase C","volume":"264","author":"R E Whatley","year":"1989","journal-title":"J Biol Chem"},{"issue":"06","key":"ref26","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0090-6980(87)90120-1","article-title":"Effect of platelet-activating factor (PAF-acether) and its specific receptor antagonist, BN 52021, on interleukin 1 (IL1) release and synthesis by rat spleen adherent monocytes","volume":"33","author":"B Pignol","year":"1987","journal-title":"Prostaglandins"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000234772","article-title":"Effect of platelet-activating factor on monocyte activation and production of tumor necrosis factor","volume":"88","author":"B Bonavida","year":"1989","journal-title":"Int Arch Allergy Appl Immunol"},{"issue":"02","key":"ref28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0161-5890(85)80003-1","article-title":"Mechanisms of complement activation by crystalline cholesterol","volume":"22","author":"W Vogt","year":"1985","journal-title":"Mol Immunol"},{"issue":"06","key":"ref29","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1172\/JCI116491","article-title":"Hypercholesterolemia increases endothelial superoxide anion production","volume":"91","author":"Y Ohara","year":"1993","journal-title":"J Clin Invest"},{"issue":"04","key":"ref30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0167-4889(84)90117-4","article-title":"Superoxide production of human polymorphonuclear leukocytes stimulated by leukotriene B4","volume":"803","author":"H Sumimoto","year":"1984","journal-title":"Biochim Biophys Acta"},{"issue":"03","key":"ref31","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4049\/jimmunol.127.3.1250","article-title":"Activation of human neutrophils with 1-O-hexadecyl\/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor)","volume":"127","author":"J O Shaw","year":"1981","journal-title":"J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000234755","article-title":"Role of cytokines and platelet-activating factor in microvascular immune injury","volume":"88","author":"P Braquet","year":"1989","journal-title":"Int Arch Allergy Appl Immunol"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/BF02536504","article-title":"Effect of platelet-activating factor on tumor necrosis factor-induced superoxide generation from human neutrophils. Possible involvement of G proteins","volume":"26","author":"P Braquet","year":"1991","journal-title":"Lipids"},{"issue":"04","key":"ref34","doi-asserted-by":"crossref","first-page":"C719","DOI":"10.1152\/ajpcell.2001.280.4.C719","article-title":"Oxidant stress and endothelial cell dysfunction","volume":"280","author":"H Lum","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"issue":"14","key":"ref35","first-page":"915","article-title":"Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity","volume":"320","author":"D Steinberg","year":"1989","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-1-1","article-title":"How hyperglycemia promotes atherosclerosis: molecular mechanisms","volume":"1","author":"D Aronson","year":"2002","journal-title":"Cardiovasc Diabetol"},{"issue":"05","key":"ref37","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCULATIONAHA.104.529297","article-title":"Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population","volume":"112","author":"C Meisinger","year":"2005","journal-title":"Circulation"},{"issue":"08","key":"ref38","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/01.CIR.0000117403.64398.53","article-title":"Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol","volume":"109","author":"H K Shin","year":"2004","journal-title":"Circulation"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/VHRM.S104369","article-title":"Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease","volume":"12","author":"P P Toth","year":"2016","journal-title":"Vasc Health Risk Manag"},{"issue":"03","key":"ref41","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1203\/00006450-200209000-00025","article-title":"The impact of serum lipid levels on circulating soluble adhesion molecules in childhood","volume":"52","author":"E Kavazarakis","year":"2002","journal-title":"Pediatr Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1476-511X-7-32","article-title":"s-ICAM-1 and s-VCAM-1 in healthy men are strongly associated with traits of the metabolic syndrome, becoming evident in the postprandial response to a lipid-rich meal","volume":"7","author":"D Rubin","year":"2008","journal-title":"Lipids Health Dis"},{"issue":"09","key":"ref43","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11886-013-0400-4","article-title":"How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis?","volume":"15","author":"F K Welty","year":"2013","journal-title":"Curr Cardiol Rep"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1161\/01.RES.0000225982.01988.93","article-title":"Endothelial and antithrombotic actions of HDL","volume":"98","author":"C Mineo","year":"2006","journal-title":"Circ Res"},{"issue":"11","key":"ref45","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/01.ATV.15.11.1987","article-title":"High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules","volume":"15","author":"G W Cockerill","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"01","key":"ref46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0021-9150(00)00659-6","article-title":"Time sequence of the inhibition of endothelial adhesion molecule expression by reconstituted high density lipoproteins","volume":"157","author":"M A Clay","year":"2001","journal-title":"Atherosclerosis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbacli.2017.07.002","article-title":"Antioxidative activity of high-density lipoprotein (HDL): mechanistic insights into potential clinical benefit","volume":"8","author":"F Brites","year":"2017","journal-title":"BBA Clin"},{"issue":"03","key":"ref48","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bbrc.2004.04.056","article-title":"Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells","volume":"318","author":"B Mackness","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"ref49","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0022-2275(20)32004-6","article-title":"International symposium on basic aspects of HDL metabolism and disease prevention","volume":"41","author":"A G Lacko","year":"2000","journal-title":"J Lipid Res"},{"issue":"08","key":"ref50","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/ATVBAHA.107.161042","article-title":"HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production","volume":"28","author":"M T\u00f6lle","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"17","key":"ref51","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1161\/01.CIR.0000127419.45975.26","article-title":"High-density lipoproteins neutralize C-reactive protein proinflammatory activity","volume":"109","author":"C Wadham","year":"2004","journal-title":"Circulation"},{"issue":"01","key":"ref52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-0033-1363423","article-title":"Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality","volume":"23","author":"K Prasad","year":"2014","journal-title":"Int J Angiol"},{"issue":"05","key":"ref53","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.RES.84.5.489","article-title":"Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis","volume":"84","author":"A M Schmidt","year":"1999","journal-title":"Circ Res"},{"issue":"01","key":"ref54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5551\/jat.RV17014","article-title":"Mechanism of development of atherosclerosis and cardiovascular disease in diabetes mellitus","volume":"25","author":"N Katakami","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1023\/A:1007079802459","article-title":"Oxidative stress as a mechanism of diabetes in diabetic BB prone rats: effect of secoisolariciresinol diglucoside (SDG)","volume":"209","author":"K Prasad","year":"2000","journal-title":"Mol Cell Biochem"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1023\/A:1007018030524","article-title":"Protective effect of secoisolariciresinol diglucoside against streptozotocin-induced diabetes and its mechanism","volume":"206","author":"K Prasad","year":"2000","journal-title":"Mol Cell Biochem"},{"issue":"04","key":"ref57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1054\/plef.2000.0204","article-title":"Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study","volume":"63","author":"G Sobal","year":"2000","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"04","key":"ref58","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MOL.0b013e328348a43f","article-title":"Susceptibility of LDL and its subfractions to glycation","volume":"22","author":"H Soran","year":"2011","journal-title":"Curr Opin Lipidol"},{"issue":"04","key":"ref59","first-page":"331","article-title":"Effect of glycated low density lipoprotein on smooth muscle cell proliferation","volume":"18","author":"T Makita","year":"1999","journal-title":"Int Angiol"},{"issue":"06","key":"ref60","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1016\/S0021-9258(19)50640-8","article-title":"Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages","volume":"267","author":"M E Haberland","year":"1992","journal-title":"J Biol Chem"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00726-003-0029-5","article-title":"Scavenger receptors for oxidized and glycated proteins","volume":"25","author":"S Horiuchi","year":"2003","journal-title":"Amino Acids"},{"issue":"07","key":"ref62","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","article-title":"RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"M A Hofmann","year":"1999","journal-title":"Cell"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.cb.10.110194.002201","article-title":"Structure, regulation and function of NF-kappa B","volume":"10","author":"U Siebenlist","year":"1994","journal-title":"Annu Rev Cell Biol"},{"issue":"07","key":"ref64","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/hc0702.104183","article-title":"Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses","volume":"105","author":"G Basta","year":"2002","journal-title":"Circulation"},{"issue":"04","key":"ref65","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/147323000703500407","article-title":"Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-activated receptor-gamma activation","volume":"35","author":"T Matsui","year":"2007","journal-title":"J Int Med Res"},{"issue":"11","key":"ref66","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1271\/bbb.63.2011","article-title":"Induction of GM-CSF production of macrophages by advanced glycation end products of the Maillard reaction","volume":"63","author":"T Sasaki","year":"1999","journal-title":"Biosci Biotechnol Biochem"},{"issue":"03","key":"ref67","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1172\/JCI117070","article-title":"Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model","volume":"93","author":"Y G Wolf","year":"1994","journal-title":"J Clin Invest"},{"issue":"01","key":"ref68","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ddstr.2008.02.001","article-title":"Oxidative mechanisms and atherothrombotic cardiovascular disease","volume":"5","author":"J A Leopold","year":"2008","journal-title":"Drug Discov Today Ther Strateg"},{"issue":"02","key":"ref69","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.atherosclerosis.2006.09.016","article-title":"Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells","volume":"193","author":"R Piga","year":"2007","journal-title":"Atherosclerosis"},{"issue":"06","key":"ref70","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1089\/ars.2010.3522","article-title":"Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants","volume":"15","author":"J M Cook-Mills","year":"2011","journal-title":"Antioxid Redox Signal"},{"issue":"01","key":"ref71","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1681\/ASN.V13186","article-title":"Reactive oxygen species alter gene expression in podocytes: induction of granulocyte macrophage-colony-stimulating factor","volume":"13","author":"S Greiber","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"S 02","key":"ref72","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.2337\/dc08-s245","article-title":"Possible role of oxidative stress in the pathogenesis of hypertension","volume":"31","author":"A Ceriello","year":"2008","journal-title":"Diabetes Care"},{"issue":"S 02","key":"ref73","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.2337\/dc08-s246","article-title":"Does increased oxidative stress cause hypertension?","volume":"31","author":"E Grossman","year":"2008","journal-title":"Diabetes Care"},{"key":"ref74","volume-title":"Hypertension","author":"K Prasad","year":"2009"},{"issue":"01","key":"ref75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0037-1598183","article-title":"Do advanced glycation end products and its receptor play a role in pathophysiology of hypertension?","volume":"26","author":"K Prasad","year":"2017","journal-title":"Int J Angiol"},{"issue":"04","key":"ref76","first-page":"358","article-title":"Oxidative stress and hypertension: Possibility of hypertension therapy with antioxidants","volume":"19","author":"A Baradaran","year":"2014","journal-title":"J Res Med Sci"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00229580","article-title":"Oxygen free radicals in essential hypertension","volume":"111","author":"S Sagar","year":"1992","journal-title":"Mol Cell Biochem"},{"issue":"03","key":"ref78","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.amjhyper.2006.08.009","article-title":"Advanced glycation end-products and arterial stiffness in hypertension","volume":"20","author":"M McNulty","year":"2007","journal-title":"Am J Hypertens"},{"issue":"09","key":"ref79","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/01.hjh.0000177535.45785.64","article-title":"Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension","volume":"23","author":"D Geroldi","year":"2005","journal-title":"J Hypertens"},{"issue":"04","key":"ref80","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s12291-009-0070-6","article-title":"Circulating levels of cell adhesion molecules in hypertension","volume":"24","author":"K K Shalia","year":"2009","journal-title":"Indian J Clin Biochem"},{"issue":"06","key":"ref81","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0002-9149(99)00862-0","article-title":"Serum profiles of granulocyte-macrophage colony-stimulating factor and C-C chemokines in hypertensive patients with or without significant hyperlipidemia","volume":"85","author":"J T Parissis","year":"2000","journal-title":"Am J Cardiol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"3159283","DOI":"10.1155\/2019\/3159283","article-title":"Arterial hypertension and interleukins: potential therapeutic target or future diagnostic marker?","volume":"2019","author":"D M Tanase","year":"2019","journal-title":"Int J Hypertens"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/bmj.298.6676.784","article-title":"Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data","volume":"298","author":"W Y Craig","year":"1989","journal-title":"BMJ"},{"issue":"09","key":"ref84","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9149(02)02284-1","article-title":"Relation between markers of systemic vascular inflammation and smoking in women","volume":"89","author":"E A Bermudez","year":"2002","journal-title":"Am J Cardiol"},{"issue":"09","key":"ref85","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1515\/CCLM.2001.136","article-title":"Cigarette smoking and hypertension influence nitric oxide release and plasma levels of adhesion molecules","volume":"39","author":"A Mazzone","year":"2001","journal-title":"Clin Chem Lab Med"},{"issue":"10","key":"ref86","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/01.ATV.17.10.2167","article-title":"Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects","volume":"17","author":"R P Tracy","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"04","key":"ref87","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1042\/cs0880485","article-title":"Cigarette smoking influences cytokine production and antioxidant defences","volume":"88","author":"P S Tappia","year":"1995","journal-title":"Clin Sci (Lond)"},{"issue":"07","key":"ref88","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/01.CIR.93.7.1346","article-title":"Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL","volume":"93","author":"T Heitzer","year":"1996","journal-title":"Circulation"},{"issue":"01","key":"ref89","first-page":"1","article-title":"Increased production of oxygen free radicals in cigarette smokers","volume":"72","author":"J Kalra","year":"1991","journal-title":"Int J Exp Pathol"},{"issue":"02","key":"ref90","first-page":"75","article-title":"Role of advanced glycation end products and its receptors in the pathogenesis of cigarette smoke-induced cardiovascular disease","volume":"24","author":"K Prasad","year":"2015","journal-title":"Int J Angiol"},{"issue":"03","key":"ref91","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1177\/0300060517723415","article-title":"Association between monocyte chemoattractant protein-1 and blood pressure in smokers","volume":"46","author":"M Komiyama","year":"2018","journal-title":"J Int Med Res"},{"issue":"02","key":"ref92","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0300-595X(76)80026-6","article-title":"Obesity and cardiovascular diseases: the Framingham study","volume":"5","author":"T Gordon","year":"1976","journal-title":"Clin Endocrinol Metab"},{"issue":"03","key":"ref93","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0021-9681(74)90079-4","article-title":"Relation of weight change to changes in atherogenic traits: the Framingham Study","volume":"27","author":"F W Ashley Jr.","year":"1974","journal-title":"J Chronic Dis"},{"issue":"03","key":"ref94","doi-asserted-by":"crossref","first-page":"e0121971","DOI":"10.1371\/journal.pone.0121971","article-title":"Inflammatory cytokines in general and central obesity and modulating effects of physical activity","volume":"10","author":"F M Schmidt","year":"2015","journal-title":"PLoS One"},{"issue":"05","key":"ref95","doi-asserted-by":"crossref","first-page":"E1038","DOI":"10.1152\/ajpendo.00061.2008","article-title":"The role of GM-CSF in adipose tissue inflammation","volume":"295","author":"D H Kim","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"11","key":"ref96","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s11695-008-9424-z","article-title":"Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass","volume":"17","author":"V Catal\u00e1n","year":"2007","journal-title":"Obes Surg"},{"issue":"02","key":"ref97","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41366-020-00667-4","article-title":"Circulating cell adhesion molecules in metabolically healthy obesity","volume":"45","author":"A Mulhem","year":"2021","journal-title":"Int J Obes"},{"issue":"01","key":"ref98","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/ijms16010378","article-title":"Oxidative stress in obesity: a critical component in human diseases","volume":"16","author":"L Marseglia","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"03","key":"ref99","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3400\/avd.ra.18-00070","article-title":"Role of hyperglycemia-induced advanced glycation end product (AGE) accumulation in atherosclerosis","volume":"11","author":"S I Yamagishi","year":"2018","journal-title":"Ann Vasc Dis"},{"issue":"04","key":"ref100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.31083\/j.rcm.2019.04.57","article-title":"AGE-RAGE stress play a role in aortic aneurysm: a comprehensive review and novel potential therapeutic target","volume":"20","author":"K Prasad","year":"2019","journal-title":"Rev Cardiovasc Med"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1016\/j.amjmed.2004.02.006","article-title":"Inflammation and atherosclerosis: role of C-reactive protein in risk assessment","volume":"116","author":"P Libby","year":"2004","journal-title":"Am J Med"},{"issue":"09","key":"ref102","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.CIR.103.9.1194","article-title":"C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis","volume":"103","author":"T P Zwaka","year":"2001","journal-title":"Circulation"},{"issue":"08","key":"ref103","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1210\/jc.2005-0069","article-title":"Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker","volume":"90","author":"S Devaraj","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"05","key":"ref104","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/1043-4666(92)90079-7","article-title":"Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein","volume":"4","author":"S P Ballou","year":"1992","journal-title":"Cytokine"},{"issue":"21","key":"ref105","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/01.CIR.103.21.2531","article-title":"Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs","volume":"103","author":"V Pasceri","year":"2001","journal-title":"Circulation"},{"issue":"18","key":"ref106","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","article-title":"Direct proinflammatory effect of C-reactive protein on human endothelial cells","volume":"102","author":"V Pasceri","year":"2000","journal-title":"Circulation"},{"issue":"04","key":"ref107","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5551\/jat.No182","article-title":"Relationships of soluble E-selectin and high-sensitivity C-reactive protein with carotid atherosclerosis in Japanese men","volume":"16","author":"S Sakurai","year":"2009","journal-title":"J Atheroscler Thromb"},{"issue":"02","key":"ref108","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11883-006-0046-4","article-title":"Homocysteine: role and implications in atherosclerosis","volume":"8","author":"S Guthikonda","year":"2006","journal-title":"Curr Atheroscler Rep"},{"issue":"05","key":"ref109","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/01.ATV.20.5.1182","article-title":"Hyperhomocysteinemia and oxidative stress: time for a reality check?","volume":"20","author":"D W Jacobsen","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"03","key":"ref110","first-page":"129","article-title":"Homocysteine altered ROS generation and NO accumulation in endothelial cells","volume":"46","author":"C M Tsen","year":"2003","journal-title":"Chin J Physiol"},{"issue":"02","key":"ref111","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0021-9150(01)00670-0","article-title":"Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells","volume":"161","author":"T Koga","year":"2002","journal-title":"Atherosclerosis"},{"issue":"03","key":"ref112","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejvs.2010.11.012","article-title":"Chronic homocysteine exposure upregulates endothelial adhesion molecules and mediates leukocyte: endothelial cell interactions under flow conditions","volume":"41","author":"K Alkhoury","year":"2011","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"06","key":"ref113","doi-asserted-by":"crossref","first-page":"H2840","DOI":"10.1152\/ajpheart.2001.280.6.H2840","article-title":"Homocysteine induces monocyte chemoattractant protein-1 expression by activating NF-kappaB in THP-1 macrophages","volume":"280","author":"G Wang","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"ref114","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1093\/jn\/133.11.3588","article-title":"Hyperhomocysteinemic subjects have enhanced expression of lectin-like oxidized LDL receptor-1 in mononuclear cells","volume":"133","author":"K B Holven","year":"2003","journal-title":"J Nutr"},{"issue":"43","key":"ref115","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1093\/eurheartj\/ehx362","article-title":"Infections, atherosclerosis, and coronary heart disease","volume":"38","author":"N VK Pothineni","year":"2017","journal-title":"Eur Heart J"},{"issue":"11","key":"ref116","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1161\/01.ATV.17.11.2910","article-title":"Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis","volume":"17","author":"A Laurila","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/bmj.314.7092.1456","article-title":"Chlamydia pneumoniae antibodies and serum lipids in Finnish men: cross sectional study","volume":"314","author":"A Laurila","year":"1997","journal-title":"BMJ"},{"issue":"03","key":"ref118","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/mpat.1996.0056","article-title":"Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response","volume":"21","author":"S S Kaukoranta-Tolvanen","year":"1996","journal-title":"Microb Pathog"},{"issue":"01","key":"ref119","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/ijms12010334","article-title":"The role of reactive-oxygen-species in microbial persistence and inflammation","volume":"12","author":"R Spooner","year":"2011","journal-title":"Int J Mol Sci"},{"issue":"06","key":"ref120","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/01.ATV.20.6.1536","article-title":"Infection and inflammation induce LDL oxidation in vivo","volume":"20","author":"R A Memon","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"02","key":"ref121","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2012.01.051","article-title":"Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis","volume":"221","author":"L E Adinolfi","year":"2012","journal-title":"Atherosclerosis"},{"issue":"01","key":"ref122","first-page":"1","article-title":"Chlamydia pneumoniae induces expression of pro-atherogenic factors through activation of the lectin-like oxidized LDL receptor-1","volume":"69","author":"L A Campbell","year":"2013","journal-title":"Pathog Dis"},{"issue":"25","key":"ref123","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1161\/01.CIR.101.25.2889","article-title":"Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells","volume":"101","author":"D Li","year":"2000","journal-title":"Circulation"},{"key":"ref124","first-page":"862504","article-title":"The effect of alcohol on postprandial and fasting triglycerides","volume":"2012","author":"A Van de Wiel","year":"2012","journal-title":"Int J Vasc Med"},{"issue":"08","key":"ref125","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/0003319714549557","article-title":"Relationship between alcohol consumption and serum lipid profiles among middle-aged population in china: a multiple-center cardiovascular epidemiological study","volume":"66","author":"G Hao","year":"2015","journal-title":"Angiology"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"1543809","DOI":"10.1155\/2016\/1543809","article-title":"Lipids and oxidative stress associated with ethanol-induced neurological damage","volume":"2016","author":"J A Hern\u00e1ndez","year":"2016","journal-title":"Oxid Med Cell Longev"},{"issue":"11","key":"ref127","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/0006-2952(82)90417-8","article-title":"A correlation between hydroxyl radical generation and ethanol oxidation by liver, lung and kidney microsomes","volume":"31","author":"G W Winston","year":"1982","journal-title":"Biochem Pharmacol"},{"key":"ref128","first-page":"427","volume-title":"Oxygen free radicals and peripheral vascular disease","author":"K Prasad","year":"2000"},{"issue":"08","key":"ref129","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/ejcn.2012.68","article-title":"The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials","volume":"66","author":"L Cai","year":"2012","journal-title":"Eur J Clin Nutr"},{"issue":"02","key":"ref130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1047-2797(98)00051-9","article-title":"Relationship of coffee consumption with serum lipids and lipoproteins in Japanese men","volume":"9","author":"Y Miyake","year":"1999","journal-title":"Ann Epidemiol"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.nut.2013.01.003","article-title":"Paper-filtered coffee increases cholesterol and inflammation biomarkers independent of roasting degree: a clinical trial","volume":"29","author":"T A Corr\u00eaa","year":"2013","journal-title":"Nutrition"},{"issue":"06","key":"ref132","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jama.1992.03480060057030","article-title":"The effect of filtered-coffee consumption on plasma lipid levels. Results of a randomized clinical trial","volume":"267","author":"R E Fried","year":"1992","journal-title":"JAMA"},{"issue":"01","key":"ref133","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/01.HYP.36.1.137","article-title":"Hypertension risk status and effect of caffeine on blood pressure","volume":"36","author":"T R Hartley","year":"2000","journal-title":"Hypertension"},{"issue":"04","key":"ref134","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.pbb.2011.06.010","article-title":"Chronic coffee and caffeine ingestion effects on the cognitive function and antioxidant system of rat brains","volume":"99","author":"R V Abreu","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"issue":"11","key":"ref135","first-page":"e563","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"D K Arnett","year":"2019","journal-title":"Circulation"},{"issue":"01","key":"ref136","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0032-1306417","article-title":"Resveratrol, wine, and atherosclerosis","volume":"21","author":"K Prasad","year":"2012","journal-title":"Int J Angiol"},{"issue":"06","key":"ref139","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jada.2010.03.018","article-title":"Advanced glycation end products in foods and a practical guide to their reduction in the diet","volume":"110","author":"J Uribarri","year":"2010","journal-title":"J Am Diet Assoc"},{"issue":"06","key":"ref140","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2174\/1381612822666161006143032","article-title":"Therapeutic interventions for advanced glycation-end products and its receptor- mediated cardiovascular disease","volume":"23","author":"K Prasad","year":"2017","journal-title":"Curr Pharm Des"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"194586","DOI":"10.1155\/2011\/194586","article-title":"Strategies for reducing or preventing the generation of oxidative stress","volume":"2011","author":"B Poljsak","year":"2011","journal-title":"Oxid Med Cell Longev"},{"issue":"05","key":"ref142","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/FJC.0b013e3181af04e5","article-title":"Flaxseed and cardiovascular health","volume":"54","author":"K Prasad","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"issue":"22","key":"ref143","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation","volume":"124","author":"S C Smith Jr.","year":"2011","journal-title":"Circulation"},{"issue":"03","key":"ref144","first-page":"289","article-title":"Secondary prevention of coronary artery disease","volume":"81","author":"S L Hall","year":"2010","journal-title":"Am Fam Physician"},{"issue":"05","key":"ref145","doi-asserted-by":"crossref","first-page":"979","DOI":"10.5114\/aoms.2017.65236","article-title":"Practice setting and secondary prevention of coronary artery disease","volume":"14","author":"P Jankowski","year":"2018","journal-title":"Arch Med Sci"},{"issue":"02","key":"ref147","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1358\/dnp.2000.13.2.662239","article-title":"Flaxseed: a source of hypocholesterolemic and antiatherogenic agents","volume":"13","author":"K Prasad","year":"2000","journal-title":"Drug News Perspect"},{"issue":"01","key":"ref148","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"F Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"01","key":"ref149","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/BF01466280","article-title":"D-lactate concentrations in blood, urine and sweat before and after exercise","volume":"65","author":"Y Kondoh","year":"1992","journal-title":"Eur J Appl Physiol Occup Physiol"},{"issue":"03","key":"ref150","first-page":"860","article-title":"A comparison between the impact of two different exercise protocols on advanced glycation end products in type 2 diabetic rats","volume":"10","author":"M EE-DM Salama","year":"2013","journal-title":"Life Sci J"},{"issue":"20","key":"ref151","doi-asserted-by":"crossref","first-page":"11119","DOI":"10.1021\/jf102762s","article-title":"Citrus fruit extracts reduce advanced glycation end products (AGEs)- and H2O2-induced oxidative stress in human adipocytes","volume":"58","author":"D Ramful","year":"2010","journal-title":"J Agric Food Chem"},{"key":"ref152","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijbiomac.2016.11.035","article-title":"Linolenic acid prevents early and advanced glycation end-products (AGEs) modification of albumin","volume":"95","author":"G Prasanna","year":"2017","journal-title":"Int J Biol Macromol"},{"issue":"03","key":"ref153","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1055\/s-0040-1710045","article-title":"AGE-RAGE axis in the pathophysiology of chronic lower limb ischemia and a novel strategy for its treatment","volume":"29","author":"K Prasad","year":"2020","journal-title":"Int J Angiol"},{"key":"ref154","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijcme.2014.07.002","article-title":"Effect of statins on the serum soluble form of receptor for advanced glycation end-products and its association with coronary atherosclerosis in patients with angina pectoris","volume":"4","author":"T Nozue","year":"2014","journal-title":"IJC Metab Endocr"},{"issue":"01","key":"ref155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.atherosclerosis.2009.08.031","article-title":"Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes","volume":"209","author":"H L Tam","year":"2010","journal-title":"Atherosclerosis"},{"issue":"11","key":"ref156","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1194\/jlr.M038968","article-title":"Statins stimulate the production of a soluble form of the receptor for advanced glycation end products","volume":"54","author":"P Quade-Lyssy","year":"2013","journal-title":"J Lipid Res"},{"issue":"08","key":"ref157","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1681\/ASN.2005010062","article-title":"Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy","volume":"16","author":"J M Forbes","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"09","key":"ref158","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s00125-007-0759-0","article-title":"Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes","volume":"50","author":"K CB Tan","year":"2007","journal-title":"Diabetologia"},{"issue":"10","key":"ref159","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1161\/01.CIR.94.10.2369","article-title":"Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering","volume":"94","author":"S P Azen","year":"1996","journal-title":"Circulation"},{"issue":"03","key":"ref160","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/ajcn\/74.3.402","article-title":"Antioxidant vitamin status and carotid atherosclerosis in the elderly","volume":"74","author":"C R Gale","year":"2001","journal-title":"Am J Clin Nutr"},{"issue":"08","key":"ref161","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ejcn.2014.296","article-title":"Effect of vitamin E supplementation on serum C-reactive protein level: a meta-analysis of randomized controlled trials","volume":"69","author":"S Saboori","year":"2015","journal-title":"Eur J Clin Nutr"},{"key":"ref162","doi-asserted-by":"crossref","first-page":"f10","DOI":"10.1136\/bmj.f10","article-title":"Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials","volume":"346","author":"S K Myung","year":"2013","journal-title":"BMJ"},{"issue":"07","key":"ref163","doi-asserted-by":"crossref","first-page":"E1717","DOI":"10.3390\/molecules25071717","article-title":"The effect of vitamin supplementation on subclinical atherosclerosis in patients without manifest cardiovascular diseases: never-ending hope or underestimated effect?","volume":"25","author":"O Mitu","year":"2020","journal-title":"Molecules"},{"key":"ref164","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1749-6632.1987.tb23761.x","article-title":"Interaction of ascorbate and alpha-tocopherol","volume":"498","author":"E Niki","year":"1987","journal-title":"Ann N Y Acad Sci"},{"issue":"07","key":"ref165","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1161\/01.CIR.0000050626.25057.51","article-title":"Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study","volume":"107","author":"R M Salonen","year":"2003","journal-title":"Circulation"},{"issue":"04","key":"ref166","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00041433-200108000-00007","article-title":"Oxidants and antioxidants in atherosclerosis","volume":"12","author":"R Mashima","year":"2001","journal-title":"Curr Opin Lipidol"},{"issue":"01","key":"ref167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(98)00173-7","article-title":"Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis","volume":"141","author":"J W Heinecke","year":"1998","journal-title":"Atherosclerosis"},{"issue":"04","key":"ref168","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/107424849700200409","article-title":"Prevention of hypercholesterolemic atherosclerosis by garlic, an antixoidant","volume":"2","author":"K Prasad","year":"1997","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"01","key":"ref169","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1527-3466.2006.00033.x","article-title":"C-reactive protein (CRP)-lowering agents","volume":"24","author":"K Prasad","year":"2006","journal-title":"Cardiovasc Drug Rev"},{"issue":"01","key":"ref170","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.freeradbiomed.2008.09.030","article-title":"Vitamin C treatment reduces elevated C-reactive protein","volume":"46","author":"G Block","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"ref171","first-page":"275","article-title":"Neovascularization of ischemic myocardium by newly isolated tannins prevents cardiomyocyte apoptosis and improves cardiac function","volume":"12","author":"X Gu","year":"2006","journal-title":"Mol Med"},{"issue":"10","key":"ref172","doi-asserted-by":"crossref","first-page":"633300","DOI":"10.3389\/fcvm.2021.633300","article-title":"Neovascularization: the main mechanism of MSCs in ischemic heart disease therapy","volume":"8","author":"W Shi","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"05","key":"ref173","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCRESAHA.111.262097","article-title":"Apelin enhances cardiac neovascularization after myocardial infarction by recruiting aplnr+ circulating cells","volume":"111","author":"D Tempel","year":"2012","journal-title":"Circ Res"},{"issue":"01","key":"ref174","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.yjmcc.2007.09.014","article-title":"Secoisolariciresinol diglucoside induces neovascularization-mediated cardioprotection against ischemia-reperfusion injury in hypercholesterolemic myocardium","volume":"44","author":"S V Penumathsa","year":"2008","journal-title":"J Mol Cell Cardiol"}],"container-title":["International Journal of Angiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1731273.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T21:25:37Z","timestamp":1673126737000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1731273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":168,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2021,11,10]]},"published-print":{"date-parts":[[2021,9]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1731273","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1061-1711","1615-5939"],"issn-type":[{"value":"1061-1711","type":"print"},{"value":"1615-5939","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,25]]}}}